Solvay Pharmaceuticals Saves $1.5 Million and Meets Validation Requirements with VMware Virtual Infrastructure

Solvay Pharmaceuticals Saves $1.5 Million and Meets Validation Requirements with VMware Virtual Infrastructure

Cover
Solvay Pharmaceuticals, Inc. is the U.S. subsidiary of the research driven group of pharmaceutical companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardio-metabolic, influenza vaccines, gastroenterology and men's and women's health.

In this case study learn how the implementation of VMware infrastructure increased scalability and performance in the datacenter. As a result, Solvay Pharmaceuticals:

  • Saved more than $1.5 million in hardware costs
  • Decreased paperwork and server procurement costs
  • Achieved server consolidation ratio of 10:1
  • Increased CPU utilization from 0-5 percent to 15-25 percent
  • Facilitated server management with VirtualCenter; four people manage more than 100 servers
  • Decreased server deployment time from 6 hours to 30 minutes
  • Achieved 585 days of continuous uptime
Vendor:
VMware, Inc.
Posted:
18 Jun 2007
Published:
01 Jan 2006
Format:
PDF
Length:
4 Page(s)
Type:
Case Study
Language:
English
Already a Bitpipe member? Login here

Download this Case Study!

By submitting you agree to receive email from TechTarget and its partners. If you reside outside of the United States, you consent to having your personal data transferred to and processed in the United States. Privacy